key: cord-0900268-yq21fwjd authors: Burgos‐Blasco, Barbara; Güemes‐Villahoz, Noemi; Donate‐Lopez, Juan; Vidal‐Villegas, Beatriz; García‐Feijóo, Julián title: Optic nerve analysis in COVID‐19 patients date: 2020-07-19 journal: J Med Virol DOI: 10.1002/jmv.26290 sha: 972f5604a342898b9a28b752a7124318c12a950c doc_id: 900268 cord_uid: yq21fwjd We read with great interest the recent article of Baig and Sanders1 regarding the neurological manifestations and the possible neuroinvasive routes opted by SARS-CoV-2. We congratulate the authors for their excellent review. This article is protected by copyright. All rights reserved. To the Editor, We read with great interest the recent article of Baig and Sanders 1 regarding the neurological manifestations and the possible neuroinvasive routes opted by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We congratulate the authors for their excellent review. Similarly to the brain, 2 OCT has been used in multiple diseases and could give insight on SARS-CoV-2 neurotropism. We aim to report changes in RNFLT in COVID-19 patients. Of a study of 17 patients examined after COVID-19 infection, we present the data of the only five patients who had baseline OCT due to previous ophthalmological exams. All patients had been examined at the Emergency Department for COVID symptoms and had tested positive for SARS-CoV-2. Patients underwent optic nerve analysis with Spectralis-OCT (Heidelberg Engineering, Heidelberg, Germany) 4 weeks after diagnosis. All peripapillary RNFLT measurements were made using a circular scan pattern centered on the optic nerve. The eye-tracking system allows any subsequent OCT scan to be scanned at exactly the same location as the prior scan. The Spectralis-OCT software calculates the average RNFLT for the overall global (360 degrees). Of the eight eyes included, seven eyes showed an increase in RNFLT (mean: 4.3 μm) compared to previous examinations ( Table 1 ). The only patient's eye that showed a decrease had glaucoma, which accounts for this thinning. The other eyes included in the series were healthy and had previous OCT due to routine exams. All patients had fever, asthenia, and cough, and three patients also presented with neurological symptoms (anosmia, ageusia, headache, or dizziness). None reported changes in vision. Four were treated with hydroxichloroquine and one of these patients with lopinavir/ritonavir too. Marinho et al 4 On the other hand, coronavirus is known to cause retinitis and optic neuritis in animal models, being viral-induced inflammation the most likely etiology. 6 This inflammation of the optic nerve could be detected with an increase of RNFLT. Change can also be caused by the relative hypoxia of tissues due to various reasons such as pneumonia and dyspnea. However, murine models with 48 hours of systemic hypoxia (10% O 2 ) have shown glial dysfunction, but no neural changes. 7 suggested that the asymptomatic hypoxemia presented by some COVID-19 patients with severe pneumonia is related to a dysfunction of cortical, and is associated with neuroinvasion of the virus. Hence, brainstem involvement could play a role in respiratory failure. 8, 9 COVID-19 treatment may also be a possible mechanism for these RNFLT changes. However, no changes in RNFL have been described with hydroxychloroquine, and we found no reports of changes associated with lopinavir/ritonavir. 10 Therefore, neither physiological age-related changes nor COVID-19 treatment appear to be responsible for our findings. For the moment, it is not known whether these changes represent a residual inflammation of the acute illness or transient changes, and the clinical significance of these findings is unknown. To the best of our knowledge, this is the first report in the literature of changes in the RNFLT possibly associated with COVID-19 infection. OCT is a reliable and reproducible method for measuring RNFLT and detects changes in RNFLT with high accuracy. Further research is warranted to establish the consequences of COVID-19 on the optic nerve. Potential neuroinvasive pathways of SARS-CoV-2: deciphering the spectrum of neurological deficit seen in coronavirus disease 2019 (COVID-19) Central nervous system involvement by severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2) Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients Retinal findings in patients with COVID-19 Age-related change in retinal nerve fiber layer thickness measured with spectral domain optical coherence tomography Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals Systemic hypoxia led to little retinal neuronal loss and dramatic optic nerve glial response The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients Peripapillary retinal nerve fiber layer thicknesses did not change in long-term hydroxychloroquine users We thank Javier Martin-Sanchez and Juan Gonzalez-Armengol. The authors declare that there are no conflict of interests.